Prelude Therapeutics
Latest round
- Series C
Last raised
- Aug 2020
Total raised
- $80M
Investors
- 2
About Prelude Therapeutics
Founded in 2016 and headquartered in Wilmington, US, Prelude Therapeutics Inc. specializes in precision oncology.00 mn in total.Prelude Therapeutics specializes in precision oncology, focusing on the development of innovative medicines aimed at addressing high unmet needs in cancer treatment. The company’s core product offerings include first-in-class, highly selective SMARCA2 and KAT6A degraders, designed to target specific oncogenic drivers and enhance treatment efficacy in cancers such as ER+ breast cancer and other solid tumors. These degrader molecules are part of a broader portfolio that also encompasses next-generation degrader antibody conjugates and selective CDK inhibitors, including CDK9 and CDK4/6 inhibitors.85 mn.In December 2023, Prelude Therapeutics Inc.15 per share on the NASDAQ. The funds will support the ongoing development of upcoming products, including innovative cancer therapies targeted for release in the near future. The company aims to expand its reach into new markets, specifically targeting regions in Europe and Asia by 2025, enhancing its global footprint in precision oncology.
Who invested in Prelude Therapeutics
2 investors across 2 rounds
See all investors in Prelude Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Prelude Therapeutics
Who invested in Prelude Therapeutics?
Prelude Therapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prelude Therapeutics raised?
Prelude Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Prelude Therapeutics last raise money?
Prelude Therapeutics's most recent round on record is a Series C, in Aug 2020.
What does Prelude Therapeutics do?
Founded in 2016 and headquartered in Wilmington, US, Prelude Therapeutics Inc.
Where is Prelude Therapeutics headquartered?
Prelude Therapeutics is headquartered in Wilmington, US.
Which VCs invest in companies like Prelude Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Prelude Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Prelude Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.